Shareholder Alert: Ademi LLP investigates whether Taro Pharmaceutical Industries Limited has obtained a Fair Price for its Public Shareholders in its transaction with its majority shareholder, Sun...

20.05.24 21:10 Uhr

Werte in diesem Artikel

MILWAUKEE, May 20, 2024 /PRNewswire/ -- Ademi LLP is investigating Taro (NYSE: TARO) for possible breaches of fiduciary duty and other violations of law in its transaction with its majority shareholder Sun.

AdemiLogo (PRNewsfoto/Ademi LLP)

Click here to learn how to join the https://www.ademilaw.com/case/taro-pharmaceutical-industries-limited or call Guri Ademi toll-free at 866-264-3995. There is no cost or obligation to you.

In the transaction, Taro's stockholders receive $43.00 in cash for each share of Taro common stock they own. Taro insiders receive substantial benefits as part of change of control arrangements and Taro's board is not likely to have been independent in its negotiation of the transaction given Sun's majority position.

We are investigating the conduct of Taro's board of directors, and whether they are fulfilling their fiduciary duties to all shareholders.

If you own Taro common stock and wish to obtain additional information, please contact Guri Ademi either at gademi@ademilaw.com or toll-free: 866-264-3995, or https://www.ademilaw.com/case/taro-pharmaceutical-industries-limited.

We specialize in shareholder litigation involving buyouts, mergers, and individual shareholder rights throughout the country. For more information, please feel free to call us. Attorney advertising. Prior results do not guarantee similar outcomes.

Contacts

Ademi LLP
Guri Ademi
Toll Free: (866) 264-3995
Fax: (414) 482-8001

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/shareholder-alert-ademi-llp-investigates-whether-taro-pharmaceutical-industries-limited-has-obtained-a-fair-price-for-its-public-shareholders-in-its-transaction-with-its-majority-shareholder-sun-pharmaceutical-industries-limited-302150273.html

SOURCE Ademi LLP

Ausgewählte Hebelprodukte auf Taro Pharmaceutical Industries

Mit Knock-outs können spekulative Anleger überproportional an Kursbewegungen partizipieren. Wählen Sie einfach den gewünschten Hebel und wir zeigen Ihnen passende Open-End Produkte auf Taro Pharmaceutical Industries

NameHebelKOEmittent
NameHebelKOEmittent
Werbung

Nachrichten zu Taro Pharmaceutical Industries Ltd.

Analysen zu Taro Pharmaceutical Industries Ltd.

DatumRatingAnalyst
12.03.2018Taro Pharmaceutical Industries BuyH.C. Wainwright & Co.
31.08.2005Taro Phamac. mit KurspotenzialGlobal Biotech Investing
23.08.2005Update Taro Pharmaceutical Industries Ltd.: StrongFirst Albany
23.08.2005Taro Pharmaceutical strong buyFirst Albany
DatumRatingAnalyst

Keine Analysen im Zeitraum eines Jahres in dieser Kategorie verfügbar.

Eventuell finden Sie Nachrichten die älter als ein Jahr sind im Archiv

Um die Übersicht zu verbessern, haben Sie die Möglichkeit, die Analysen für Taro Pharmaceutical Industries Ltd. nach folgenden Kriterien zu filtern.

Alle: Alle Empfehlungen

Buy: Kaufempfehlungen wie z.B. "kaufen" oder "buy"
Hold: Halten-Empfehlungen wie z.B. "halten" oder "neutral"
Sell: Verkaufsempfehlungn wie z.B. "verkaufen" oder "reduce"